As psychedelic therapies move toward mainstream medical access, David Bronner argues that reform must reach beyond clinics and FDA approval. Drawing on Alaska’s Indigenous-led policy model, the Sacred Plant Alliance, and conservation efforts for peyote, iboga, ayahuasca, and Huachuma, he makes the case for Indigenous-led access, plant conservation, and self-regulating communities built around safety and reciprocity.Continue Reading